CLOs on the Move

Kao Brands

www.kaobrands.com

 
Kao Brands Company is a leading manufacturer of premium beauty care brands that are recognized around the world for their innovation and quality.
  • Number of Employees: 250-1000
  • Annual Revenue: > $1 Billion
  • www.kaobrands.com
  • 2535 Spring Grove Ave
    Cincinnati, OH USA 45214
  • Phone: 513.421.1400

Executives

Name Title Contact Details

Similar Companies

Mash Medical Aid Supply House

Mash Medical Aid Supply House is a Duluth, GA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Olmsted Medical Center

Olmsted Medical Center is a Rochester, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Deer Meadows Retirement Community

Deer Meadows Retirement Community is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Deer Meadows Retirement Community is based in Philadelphia, PA. You can find more information on Deer Meadows Retirement Community at www.deer-meadows.org

Accord BioPharma

Foresee is a Taiwan and US-based biopharmaceutical company listed on the Taipei Exchange (6576.TWO). Foresee`s R&D efforts are focused in two key areas, namely its unique stabilized injectable formulation (SIF) depot delivery technology with derived drug products targeting specialty markets, and secondly its transformative preclinical and clinical first-in-class NCE programs targeting rare and severe disease areas with high unmet needs. Foresee`s product portfolio includes late stage and early stage programs. CAMCEVI® 42 mg is now approved in the U.S. and under regulatory review in the EU. Additionally, U.S. and EU regulatory submissions are in preparation for CAMCEVI® 21 mg. FP-025 – a highly selective oral MMP-12 inhibitor targeting inflammatory and fibrotic diseases, currently in Phase 2/3 studies, including a Phase 2/3 study for COVID-19 virus-induced acute respiratory distress syndrome (ARDS). FP-045 – a highly selective oral small molecule allosteric activator of ALDH2, a mitochondrial enzyme, for which a Phase 1b/2 study is currently planned for Fanconi Anemia.

Nexeon MedSystems

Nexeon MedSystems is a Carlsbad, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.